市場調查報告書
商品編碼
1123156
移植用HLA分型的全球市場:預測(2022年~2028年)Global HLA Typing for Transplant Market Research and Forecast 2022-2028 |
全球移植用HLA(人類白血球抗原)分型的市場規模,預計在預測期間內以約6.4%的年複合成長率擴大。由於器官功能衰竭的移植手術增加,成為促進HLA分型市場成長的主要原因。
本報告提供全球移植用HLA分型市場相關調查,市場概要,以及各技術,產品、各服務,各用途,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。
Global HLA Typing for Transplant Market Size, Share & Trends Analysis Report By Type (Molecular Assays, and Non-Molecular Assays) By Product & Services (Reagents, Software, and Instruments) By Application (Diagnostics, and Research) By End-Users (Academic Institutes & Research Centers, Hospitals & Transplant Centers, and others) Forecast, 2021-2027
The global human leukocyte antigen (HLA) typing for the transplant market is anticipated to grow at a CAGR of around 6.4% during the forecast period. HLA Typing transplant is an efficient method of matching the tissues of the potential donor with the recipient of the respective tissues. HLA typing is an important procedure used in the transplantation of stem cells, kidney, liver, pancreas, heart transplant, and bone marrow. The increasing number of transplantation procedures owing to the rising number of organ failures is the major factor driving the growth of the HLA Typing. According to the Health Resource & Service Administration, US Department of Health and Human Services, in the US, 107,000+ men, women, and children are on the national transplant waiting list as of February 2021, 39,000 transplants were performed in 2020, and 17 people die every day waiting for an organ transplant. Among all the other organs, Kidney transplantation is on the highest in 2020 which is 20,000, and around 90,000 people are on the waiting list.
Moreover, the increasing geriatric population and growing awareness among the population regarding the importance of organ donation are some of the factors propelling the growth of the global HLA Typing. The US accounted for the largest region with the geriatric population. For instance, the Centers for Disease Control and Prevention predicts that 72 million Americans will be aged 65 years old or older by 2030, accounting for approximately 20% of the United States population. These increasing numbers of elderly populations will inevitably lead to increased chances of organ failures, and transplantation of organs such as kidneys and others. However, the high cost of typing devices and stringent reimbursement policies are some factors limiting the growth of the global HLA Typing. Whereas, the improvement in the healthcare sector in emerging economies such as China, rising demand for low-cost DNA sequencing technology, and increasing public-private funding for R&D activities are likely to fuel the market growth shortly.
Impact of COVID-19 on global HLA Typing for Transplant Market
The global market for HLA typing for transplant is hit by the outbreak of the COVID-19 pandemic. Many hospitals and transplant centers have faced disruption in diagnosis procedures and transplantation due to the lack of transplant diagnostic products and a smaller number of transplant donors. Moreover, the halt in R&D activities by pharmaceutical & biotechnology companies due to the decrease in the public-private fund has negatively affected the market.
Segmental Outlook
The HLA typing for transplant market is segmented based on technology, product & services, application, and end-users. Based on technology, the market can be diversified into non-molecular assays and molecular assays. Non-molecular assays can be further segmented into serological assays and mixed lymphocyte culture assays. Moreover, the molecular assays segment can be further segmented into PCR-based molecular assays and sequencing-based molecular assays. The PCR-based molecular assays are further sub-segmented into sequence-specific primer (SSP-PCR), sequence-specific oligonucleotide (SSO-PCR), sequence-based typing (SBT-PCR), and reference strand-based conformation analysis (RSCA-PCR). The sequencing-based molecular assays can be further sub-segmented into Sanger sequencing and next-generation sequencing. Based on product & services, the market is bifurcated into reagents, software, and instruments. Based on applications, the market is segmented into diagnostics and research. Based on end-users, the market is segmented into academic institutes & research centers, hospitals & transplant centers, and donor registries. Among end-users, the hospital segment holds the largest market share in the HLA Typing. This can be attributed to the growing number of hospitals emerging economies due to the rapid investment in healthcare infrastructure.
Global HLA Typing for Transplant Market Share By Technology, 2020 (%)
Global HLA Typing for Transplant Market Share By Technology
The Molecular Assay Segment is Projected to Exhibit the Largest Share in HLA typing for transplants market
Among technology, the molecular assay sub-segment held a considerable market share in 2020, and it is projected to exhibit the largest market share in the HLA typing for transplant market during the forecast period. The market for the molecular assay is further analyzed based on PCR-based molecular assays, and sequencing-based molecular assay. Among these, the PCR-based molecular assay dominated the market and it is expected to maintain its dominance in future years. The advantages associated with PCR molecular assay such as real-time sample analysis, the higher degree of accuracy, faster results, among others is the key reason for the large adoption of this molecular assay in various end-users includes hospitals and transplant centers, and academic institutes & research centers.
Regional Outlook
Geographically, the global HLA typing for transplant market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, ASEAN and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Asia-Pacific is projected to witness the fastest growth in the global HLA typing for transplant market. The major economies contributing to the growth of the region include China, Japan, India, and South Korea. The factors attributing to the growth of the HLA typing for transplant market in the Asia-Pacific region include the increasing geriatric population with a large number of organ failure, advanced healthcare facilities, and rising public-private funding for research activities for molecular diagnosis.
Global HLA Typing for Transplant Market Growth, By Region 2021-2027
Global HLA Typing for Transplant Market Growth, By Region
North America Holds the Largest Market Share in Global HLA Typing for Transplant Market
Geographically, North America held the largest share in the global HLA typing for transplant market, and it is anticipated to grow at a significant CAGR during the forecast period. The market growth in the region is mainly attributed to the increasing demand for organ transplants and the rising number of organ donors in the region. The US is the region with a large pool of potential organ donors driving the growth of the region. According to Organ Donation Facts and Statistics, every 10 minutes another person is added to the national transplant list, and 95% of Americans are in favor of being a donor. Moreover, the improvement in the healthcare infrastructure, and adoption of transplant technologies such as HLA, and awareness programs are the factors driving the growth of the HLA typing market in North America.
Market Players Outlook
The key players in the HLA typing for transplant market contributing significantly by providing different types of products and increasing their geographical presence across the globe. The key players of the market include Biofortuna Ltd., Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche Ltd., Illumina, Inc., Luminex Corp., Qiagen GmbH, Thermo Fisher Scientific Inc., among others. These market players are adopting several market strategies including product launch and approvals, merger and acquisition, partnership collaboration, business, and capacity expansion and others. For instance, in April 2020, Creative Biolabs has developed a dedicated NGS-based HLA typing services to facilitate their global clients with related research to disease defense, protection from cancers, organ transplant rejections and biomarkers. The company has also extended the coverage of HLA types, including HLA-A, B, C, G, DRB1, DRB3, DRB4, DRB5, DQA1, DQB1, DPA1, DPB1.
The Report Covers
Choose License Type
Single user $4500, $3375 Multi user $6000, $4500
100% Secured Payment
SHARE ON:
Benefits Of Buying From Us
Covers more than 15 major industries, which are further segmented into 90+ sectors
65% of our clients are loyal customers
120+ countries are covered in analysis
currently servicing 1000+ customers globally
100+ paid data sources mined to research
Our expert team will assist you with all research need and customization
Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports
Cancer Stem Cells (CSCs) Market
Hematopoietic Stem Cell Transplantation Market
Gene Therapy Products Market
In Vivo Toxicology Market
Veterinary Reference Laboratory Market
Microfluidics Market
Live Attenuated Vaccines Market